More FDA Publishes Final Q&A Paper on Risk-Based Monitoring of Clinical Trials
More Good Machine Learning Practice: FDA issues Discussion Paper on AI/ML in Drug Development
More FDA Recommendations to reduce HIV Transmission through Blood and Blood Products
More Publication of the 21st Edition of the EDQM Blood Guide
More FDA Form 483 due to Insufficient Investigations after OOS and OOT Results
More Consequences of manufacturing non-pharmaceutical Products on pharmaceutical Equipment
More USP: Chapter "<2> Oral Drug Products - Product Quality Tests" published for Comments
More New EMA Guidance to prevent and mitigate Medicine Shortages
More FDA Paper on Artificial Intelligence in the Manufacture of Medicines
More Summary of the MHRA Good Distribution Practice Symposium 2023
More Questions and Answers from the ECA Webinar "GDP Update 2023" - Part 2
More Medical Cannabis in Germany: From the BtMG to the Cannabis Act?
More Draft of USP Chapter <711> Dissolution (PDG harmonized document) Published for Comments
More Dead Leg in Pharmaceutical Water System leads to Warning Letter
More Cloud Computing: Is a check list for the assessment of a Cloud Service Provider sufficient?